SYNLAB Expands Investment In Italy With Opening Of Flagship Medical Centre In Florence

2025-10-09 02:09:17

(MENAFN- EQS Group)

SYNLAB / Key word(s): Expansion
SYNLAB expands investment in Italy with opening of flagship Medical Centre in Florence
09.10.2025 / 15:00 CET/CEST
The issuer is solely responsible for the content of this announcement.

New SYNLAB Manifattura Firenze Medical Centre marks a milestone in the Group's international growth strategy, strengthening local healthcare through innovation and care excellence
SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, officially inaugurated its largest medical centre in Italy today: SYNLAB Manifattura Firenze. Located in the heart of one of Italy's most ambitious urban regeneration projects, the new centre is a strategic investment in the future of healthcare, combining cutting-edge diagnostics, patient-centred care and sustainable infrastructure.
Spanning over 4,000 square metres across four floors, the centre is designed to serve over 200,000 patients annually. It is equipped with the latest diagnostic technologies and offers a comprehensive range of services, including laboratory testing, advanced imaging, specialist consultations, and a dedicated women's health area. Over 80 healthcare professionals will work at the facility, which is fully integrated into SYNLAB's regional network in Tuscany, comprising over 40 blood collection points, ten medical centres and a central laboratory in Calenzano.
“The opening of SYNLAB Manifattura Firenze is a powerful demonstration of our commitment to advancing high-quality, highly specialised diagnostics across our global network. From Europe to Latin America, SYNLAB enables personalised medicine by combining cutting-edge technology, medical excellence and a deep understanding of local healthcare needs. This new centre reflects our ambition to deliver sustainable, patient-focused solutions that support healthier lives wherever we operate, and represents another significant milestone in our international journey” said Mathieu Floreani, CEO of SYNLAB Group.
The facility was designed with a strong focus on patient experience, sustainability and efficiency. Built in just over two years, it meets the highest environmental standards, with energy-saving systems, reduced emissions, and optimised patient flows to ensure comfort and care continuity.
The opening of the Florence centre follows a series of strategic developments by SYNLAB in Italy, including the recent acquisition of the Pavanello Group, a well-established diagnostics provider in the Veneto region. These investments reflect SYNLAB's long-term commitment to expanding its presence and enhancing healthcare access across the country.
“We believe that innovation and proximity go hand in hand,” said Andrea Buratti, CEO of SYNLAB Italy.“With Manifattura Firenze, we are creating a space where people feel welcomed, supported, and empowered to take care of their health – from prevention to diagnosis and beyond.”
– End –
For more information:

Media contact: Steffi Susan Kim, FTI Consulting	... +49 (0) 171 5565 996
Investor contact:	...

About SYNLAB

SYNLAB Group is a leader in medical diagnostic services and specialty testing in Europe. The Group offers a full range of innovative and reliable medical diagnostics to patients, practising doctors, hospitals and clinics, governments, and corporates.
Providing the leading level of service within the industry, SYNLAB is the partner of choice for routine and specialty diagnostics in human medicine. The Group continuously innovates medical diagnostic services for the benefit of patients and customers.
SYNLAB operates in more than 20 countries across four continents and holds leading positions in most markets, regularly reinforcing the strength of its network through a proven acquisition strategy. More than 24,000 employees, including over 2,000 medical experts, contribute every day to the Group's worldwide success.
SYNLAB performed around 600 million laboratory tests and achieved revenues of €2.62 billion in 2024.
More information can be found on

09.10.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

2210638 09.10.2025 CET/CEST

MENAFN09102025004691010666ID1110174719

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.